Margaret K Hahn

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. doi Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters
    Margaret K Hahn
    Center for Addiction and Mental Health, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
    Clin Schizophr Relat Psychoses 6:186-96. 2013
  2. ncbi Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effects
    Margaret K Hahn
    Center for Addiction and Mental Health, 250 College Street, Toronto, Ontario, Canada
    J Clin Psychopharmacol 30:706-10. 2010
  3. doi Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients
    Arun K Tiwari
    Neurogenetics Section, Neuroscience Department, Centre forAddiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    J Clin Psychopharmacol 33:11-7. 2013
  4. doi Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal model
    Margaret K Hahn
    Center for Addiction and Mental Health, 250 College Street, Toronto, Ontario, Canada M5T 1R8 Institute of Medical Sciences, University of Toronto, 1 King s College Circle, Toronto, Ontario, Canada M5S 1A8 Electronic address
    Eur Neuropsychopharmacol 24:448-58. 2014

Collaborators

Detail Information

Publications4

  1. doi Topiramate in schizophrenia: a review of effects on psychopathology and metabolic parameters
    Margaret K Hahn
    Center for Addiction and Mental Health, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
    Clin Schizophr Relat Psychoses 6:186-96. 2013
    ....
  2. ncbi Topiramate augmentation in clozapine-treated patients with schizophrenia: clinical and metabolic effects
    Margaret K Hahn
    Center for Addiction and Mental Health, 250 College Street, Toronto, Ontario, Canada
    J Clin Psychopharmacol 30:706-10. 2010
    ..These findings support topiramate as a viable augmentation strategy in clozapine partial responders, with evidence of both clinical and metabolic benefits...
  3. doi Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients
    Arun K Tiwari
    Neurogenetics Section, Neuroscience Department, Centre forAddiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    J Clin Psychopharmacol 33:11-7. 2013
    ..011).Our observation of association of NPY polymorphisms gives further evidence for a genetic influence on antipsychotic-induced BWG and suggests a role of NPY gene in influencing this complex adverse effect...
  4. doi Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: an animal model
    Margaret K Hahn
    Center for Addiction and Mental Health, 250 College Street, Toronto, Ontario, Canada M5T 1R8 Institute of Medical Sciences, University of Toronto, 1 King s College Circle, Toronto, Ontario, Canada M5S 1A8 Electronic address
    Eur Neuropsychopharmacol 24:448-58. 2014
    ..002). In conclusion, we demonstrate novel findings that at least part of the effect of olanzapine on beta-cell function in vivo is central...